A Case of Sarcoidosis That Improved upon Discontinuation of Etanercept
Journal of Rheumatic Diseases
;
: 187-192, 2016.
Artículo
en Inglés
| WPRIM
| ID: wpr-173096
ABSTRACT
A 31-year-old man who had been prescribed etanercept over a 3-year period for treatment of ankylosing spondylitis presented with newly developed dry cough, chills, myalgia, and weight loss. Chest computed tomography showed multiple reticulonodular pulmonary infiltrates and bilateral mediastinal, hilar, and peribronchial lymphadenopathy. Biopsy of a paratracheal lymph node revealed chronic granulomatous inflammation without necrosis, and the serum angiotensin-converting enzyme level was elevated. Sarcoidosis was diagnosed. His laboratory and radiological findings, and clinical symptoms improved only after discontinuation of etanercept without treatment. Although etanercept-induced sarcoidosis is rare, this case report suggests that sarcoidosis should be considered in the differential diagnosis of patients treated with the tumor necrosis factor inhibitor.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Sarcoidosis
/
Espondilitis Anquilosante
/
Tórax
/
Biopsia
/
Pérdida de Peso
/
Factor de Necrosis Tumoral alfa
/
Tos
/
Escalofríos
/
Diagnóstico Diferencial
/
Mialgia
Tipo de estudio:
Estudio diagnóstico
Límite:
Adulto
/
Humanos
Idioma:
Inglés
Revista:
Journal of Rheumatic Diseases
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS